A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-13 and is reviewed periodically as new material appears.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516; GW-1516; endurobol | GW501516 is the research code |
| Drug class | PPARδ agonist | Not a selective androgen receptor modulator |
| Molecular formula | C21H18F3NO3S2 | Established chemical formula |
| Molar mass | 453.5 g/mol | Calculated from the formula |
| Regulatory status | Prohibited in sport; not approved as medicine | Status varies by country |
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
The bergamot essential oil is particularly subject to adulteration being an essential oil produced in relatively small quantities. Generally adulteration is to "cut" the oil, i.e. adding distilled essences of poor quality and low cost, for example of bitter orange and bergamot mint and/or mixtures of terpenes, natural or synthetic, or "reconstruct" the essence from synthetic chemicals, coloring it with chlorophyll. Worldwide, each year, around three thousand tonnes of declared essence of bergamot are marketed, while the genuine essence of bergamot produced annually amounts to no more than one hundred tons. Natural source analysis based on the Carbon-14 method can identify adulterated essences by detecting synthetic chemicals manufactured from petroleum that are used to mimic the chemical profile of bergamot oil and other essential oils. Gas chromatography with columns having a chiral stationary phase allows analyzing mixtures of enantiomers. The analysis of the enantiomeric distribution of various compounds, such as linalyl acetate and linalool, allows the characterization of the bergamot oil according to the manufacturing process and allows for the detection of possible adulteration. The combined use of isotope ratio mass spectrometry and SNIF-NMR (Site-Specific Natural Isotope Fractionation-Nuclear Magnetic Resonance) allows discovering adulteration otherwise undetectable even allowing for the identification of the geographical origin of the essential oil.
=== Morphological variation === Plants exhibit natural variation in their form and structure. While all organisms vary from individual to individual, plants exhibit an additional type of variation. Within a single individual, parts are repeated which may differ in form and structure from other similar parts. This variation is most easily seen in the leaves of a plant, though other organs such as stems and flowers may show similar variation. There are three primary causes of this variation: positional effects, environmental effects, and juvenility.
== External links == GLUT4+Protein at the U.S. National Library of Medicine Medical Subject Headings (MeSH) USCD—Nature molecule pages: The signaling pathway, "GLUT4"; contains a high-resolution network map. Accessed 25 December 2009.
Copper excess is a subject of much current research. Distinctions have emerged from studies that copper excess factors are different in normal populations versus those with increased susceptibility to adverse effects and those with rare genetic diseases. This has led to statements from health organizations that could be confusing to the uninformed. For example, according to a U.S. Institute of Medicine report, the intake levels of copper for a significant percentage of the population are lower than recommended levels. On the other hand, the U.S. National Research Council concluded in its report Copper in Drinking Water that there is concern for copper toxicity in susceptible populations and recommended that additional research be conducted to identify and characterize copper-sensitive populations. Excess copper intake causes stomach upset, nausea, and diarrhea and can lead to tissue injury and disease. The oxidation potential of copper may be responsible for some of its toxicity in excess ingestion cases. At high concentrations copper is known to produce oxidative damage to biological systems, including peroxidation of lipids or other macromolecules. While the cause and progression of Alzheimer's disease are not well understood, research indicates that, among several other key observations, iron, aluminum, and copper accumulate in the brains of Alzheimer's patients. However, it is not yet known whether this accumulation is a cause or a consequence of the disease.
=== Adobe ColdFusion (2016 Release) === Adobe ColdFusion (2016 release), known generically as ColdFusion 2016 was released on February 16, 2016. During development, it was codenamed Raijin. New or improved features available in all editions (Standard, Enterprise, and Developer) include:
Sources: en.wikipedia.org
The number and diversity of subunits contained in the 20S core particle depends on the organism; the number of distinct and specialized subunits is larger in multicellular than unicellular organisms and larger in eukaryotes than in prokaryotes. All 20S particles consist of four stacked heptameric ring structures that are themselves composed of two different types of subunits; α subunits are structural in nature, whereas β subunits are predominantly catalytic. The α subunits are pseudoenzymes homologous to β subunits. They are assembled with their N-termini adjacent to that of the β subunits. The outer two rings in the stack consist of seven α subunits each, which serve as docking domains for the regulatory particles and the alpha subunits N-termini (Pfam PF10584) form a gate that blocks unregulated access of substrates to the interior cavity. The inner two rings each consist of seven β subunits and in their N-termini contain the protease active sites that perform the proteolysis reactions. Three distinct catalytic activities were identified in the purified complex: chymotrypsin-like, trypsin-like and peptidylglutamyl-peptide hydrolyzing. The size of the proteasome is relatively conserved and is about 150 angstroms (Å) by 115 Å. The interior chamber is at most 53 Å wide, though the entrance can be as narrow as 13 Å, suggesting that substrate proteins must be at least partially unfolded to enter.
ester A class of organic and inorganic compounds derived from the reaction of an acid with an alcohol, in which at least one hydroxyl group (–OH) is replaced by an alkoxy group (–O–). Esters have the general formula RCO2R′, where R and R' represent any alkyl or aryl group.
=== Urinary tract infections === Urinary tract infections (UTIs) are often due to E. coli entering the urethra and colonizing. The host's immune system will release protamines and other antimicrobials to combat the infection, but OmpT easily degrades the cationic protamine peptides, thus enhancing the risk of infection. There is a genetic link between OmpT and other UTI-mediating factors (such as kpsMT, cnf1, prf, and sfa), but the functional link between these proteins is not well defined.
Based on Moseley and Siegbahn's research, it was also known which atomic numbers corresponded to missing elements yet to be found: 43, 61, 72, 75, 85, and 87. (Element 75 had in fact already been found by Japanese chemist Masataka Ogawa in 1908 and named nipponium, but he mistakenly assigned it as element 43 instead of 75 and so his discovery was not generally recognized until later. The contemporarily accepted discovery of element 75 came in 1925, when Walter Noddack, Ida Tacke, and Otto Berg independently rediscovered it and gave it its present name, rhenium.) The dawn of atomic physics also clarified the situation of isotopes. In the decay chains of the primordial radioactive elements thorium and uranium, it soon became evident that there were many apparent new elements that had different atomic weights but exactly the same chemical properties. In 1913, Frederick Soddy coined the term "isotope" to describe this situation, and considered isotopes to merely be different forms of the same chemical element. This furthermore clarified discrepancies such as tellurium and iodine: tellurium's natural isotopic composition is weighted towards heavier isotopes than iodine's, but tellurium has a lower atomic number.
Several naturally-preserved, unintentional mummies dating from the Incan period (1438–1532 AD) have been found in the colder regions of Argentina, Chile, and Peru. These are collectively known as "ice mummies". The first Incan ice mummy was discovered in 1954 atop El Plomo Peak in Chile, after an eruption of the nearby volcano Sabancaya melted away ice that covered the body. The Mummy of El Plomo was a male child who was presumed to be wealthy due to his well-fed bodily characteristics. He was considered to be the most well-preserved ice mummy in the world until the discovery of Mummy Juanita in 1995. Mummy Juanita was discovered near the summit of Ampato in the Peruvian section of the Andes mountains by archaeologist Johan Reinhard. Her body had been so thoroughly frozen that it had not been desiccated; much of her skin, muscle tissue, and internal organs retained their original structure. She is believed to be a ritual sacrifice, due to the close proximity of her body to the Incan capital of Cusco, as well as the fact she was wearing highly intricate clothing to indicate her special social status. Several Incan ceremonial artifacts and temporary shelters uncovered in the surrounding area seem to support this theory. More evidence that the Inca left sacrificial victims to die in the elements, and later be unintentionally preserved, came in 1999 with the discovery of the Llullaillaco mummies on the border of Argentina and Chile. The three mummies are children, two girls and one boy, who are thought to be sacrifices associated with the ancient ritual of qhapaq hucha.
Sources: en.wikipedia.org
Reactive hypoglycemia, postprandial hypoglycemia, or sugar crash is symptomatic hypoglycemia occurring within four hours after a high-carbohydrate meal in people with and without diabetes. The term is not necessarily a diagnosis since it requires an evaluation to determine the cause of the hypoglycemia. The condition is related to homeostatic systems used by the body to control the blood sugar level. It is described as a sense of tiredness, lethargy, irritation, or hangover, although the effects can be lessened if a lot of physical activity is undertaken in the first few hours after food consumption. The alleged mechanism for the feeling of a crash is correlated with an abnormally rapid rise in blood glucose after eating. This normally leads to insulin secretion (known as an insulin spike), which in turn initiates rapid glucose uptake by tissues, either storing it as glycogen or fat, or using it for energy production. The consequent fall in blood glucose is indicated as the reason for the "sugar crash". Another cause might be hysteresis effect of insulin action, i.e., the effect of insulin is still prominent even if both plasma glucose and insulin levels were already low, causing a plasma glucose level eventually much lower than the baseline level. Sugar crashes are not to be confused with the after-effects of consuming large amounts of protein, which produces fatigue akin to a sugar crash, but are instead the result of the body prioritising the digestion of ingested food.
=== Continental Europe === A translation of the Oxford team's 1941 report reached Germany via Sweden the following year. On 6 December 1943, the Reich Health Ministry ordered the medical community to conduct research into penicillin and other antibiotics. Three vials of penicillin captured by the Afrika Korps reached Germany in 1943 and one was sent to Heinz Öppinger at Hoechst in Frankfurt, who began conducting experiments with moulds. Penicillin was produced there in 300-litre batches, and Öppinger developed a rotating drum for a deep-tank fermentation process. Research was also carried out by Schering in Berlin using a sample of Fleming's mould, which they failed to cultivate; their efforts to determine the chemical structure of penicillin were also unsuccessful. Maria Brommelhues at IG Farben's Bacteriological Laboratory in Elberfeld catalogued different species of penicillin. Hitler's personal physician, Theodor Morell, treated Hitler with penicillin for injuries sustained in the 20 July 1944 assassination attempt. Information about penicillin research in Germany was gathered by the Manhattan Project's Alsos Mission and forwarded to Florey in the UK. Much of Germany's penicillin came from Czechoslovakia, where research was carried out at Charles University in Prague and the Fragner Pharmaceutical Company by a team that included chemist Karel Wiesner. Work was also conducted in secret in France and at the Delft University of Technology in the Netherlands.
=== ColdFusion MX 7 === With the release of ColdFusion 7.0 on February 7, 2005, the naming convention was amended, rendering the product name "Macromedia ColdFusion MX 7" (the codename for CFMX7 was "Blackstone"). CFMX 7 added Flash-based and XForms-based web forms, and a report builder that output in Adobe PDF as well as FlashPaper, RTF and Excel. The Adobe PDF output is also available as a wrapper to any HTML page, converting that page to a quality printable document. The enterprise edition also added Gateways. These provide interaction with non-HTTP request services such as IM Services, SMS, Directory Watchers, and an asynchronous execution. XML support was boosted in this version to include native schema checking. ColdFusion MX 7.0.1 (codename "Merrimack") added support for Mac OS X, improvements to Flash forms, RTF support for CFReport, the new CFCPRoxy feature for Java/CFC integration, and more. ColdFusion MX 7.0.2 (codenamed "Mystic") included advanced features for working with Adobe Flex 2 as well as more improvements for the CF Report Builder.
== Discovery == Notch was discovered in a mutant Drosophila in March 1913 in the lab of Thomas Hunt Morgan. This mutant emerged after several generations of crossing out and back-crossing beaded winged flies with wild type flies and was first characterized by John S. Dexter. The most frequently observed phenotype in Notch mutant flies is the appearance of a concave serration at the most distal end of the wings, for which the gene is named, accompanied by the absence of marginal bristles. This mutant was found to be a sex-linked dominant on the X chromosome that could only be observed in heterozygous females as it was lethal in males and homozygous females. The first Notch allele was established in 1917 by Charles William Metz and Calvin Bridges. In the late 1930s, studies of fly embryogenesis done by Donald F. Poulson provided the first indication of Notch's role in development. Notch mutant males exhibited a lack of the inner germ layers, the endoderm and mesoderm, that resulted in failure to undergo later morphogenesis embryonic lethality. Later studies in early Drosophila neurogenesis provided some of the first indications of Notch's roll in cell-cell signaling, as the nervous system in Notch mutants was developed by sacrificing hypodermal cells. Starting in the 1980s researchers began to gain further insights into Notch function through genetic and molecular experiments.
passivation The process of coating a substance with a thin layer of a protective material, often a metal oxide, to create a shield against corrosion or other chemical reactions with the environment, thereby rendering the coated substance "passive" or less susceptible to undesirable reactions.
Sources: en.wikipedia.org
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.
No. It has no approved medical indication in any country. Regulatory agencies have not cleared it for treatment or prevention of any condition.
Early clinical work stopped after rodent carcinogenicity findings. Those animal results raised concerns about long-term human risk, although direct human evidence is lacking. The human relevance of the tumors remains an open scientific question.
It binds to and activates PPAR delta, a nuclear receptor that controls expression of genes related to fatty acid oxidation. This mechanism can alter energy metabolism in animal models. It is not a direct stimulant or fat-burning enzyme.